论文信息 - First-in-human evaluation of the safety and immunogenicity of a recombinant adenovirus serotype 26 HIV-1 Env vaccine (IPCAVD 001). - 字舞流文

First-in-human evaluation of the safety and immunogenicity of a recombinant adenovirus serotype 26 HIV-1 Env vaccine (IPCAVD 001).

Jennifer A. Johnson | J. Goudsmit | D. Barouch | M. Seaman | Lauren Peter | P. Abbink | M. Weijtens | M. Pau | R. Dolin | L. Baden | M. Iampietro | M. Wolff | Elise Zablowsky | J. Kleinjan | A. Cheung | J. Perry | Alka Patel | E. Swann | S. Walsh | K. Krause | L. Peter | Katherine E. Yanosick | H. Loblein | R. Tucker | Lindsey R. Baden | Michael S. Seaman | Jennifer E. Johnson | Robert Tucker | Lindsey R Baden